Poolbeg Pharma has concluded a transformative year marked by substantial progress across its clinical pipeline, according to chief executive Jeremy Skillington in a recent interview. The biopharmaceutical company has advanced
Poolbeg Pharma has concluded a transformative year marked by substantial progress across its clinical pipeline, according to chief executive Jeremy Skillington in a recent interview. The biopharmaceutical company has advanced






